KING OF PRUSSIA, PA — CluePoints has announced the full agenda and speaker lineup for the highly anticipated RBQMLive 2024. Scheduled for September 24-25, this virtual event promises an in-depth exploration of advancements in RBQM, drawing participants from diverse sectors interested in enhancing clinical trial methodologies.
RBQMLive 2024 will feature a series of expert-led discussions, workshops, and networking sessions, all offered at no cost to attendees. Last year, more than 1,000 delegates from 375 organizations participated, and this year’s event aims to exceed those numbers by providing new opportunities for collaboration and innovation in the clinical trial landscape.
The event kicks off with a keynote address, “Unlocking the Path to RBQM Maturity,” by Ken Getz, Executive Director and Professor at Tufts Center for the Study of Drug Development. Getz will provide insights into the growing adoption of RBQM, highlighting factors that facilitate or hinder its implementation based on recent research findings.
Day one also features sessions on the Risk-Based Data Management (RBDM) revolution, led by industry leaders such as Miguel Valenzuela from Alnylam and Paul MacDonald from Veeva. Another notable session, “The Emergence of AI & ML in RBQM,” will be presented by Marcin Makowski of GSK and Bob Zambon of Syneos Health, exploring current applications and future potential of these technologies in RBQM.
Day two will focus on the future of RBQM, enhancing data quality, and optimizing study oversight. Key sessions include discussions on evolving industry guidance with experts like Olivia Feiro from CSL Behring and Lotte Smets from Julius Clinical. The agenda also covers advanced audit trail reviews and integrated data review processes aimed at refining study oversight.
Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, emphasized the event’s significance, stating, “Risk-based quality management is evolving, and industry adoption is increasing fast. RBQMLive is a unique event which brings together global specialists, industry experts and anyone who is interested in finding out more about this transformative approach to managing clinical trials.”
RBQMLive 2024 provides a crucial platform for professionals to engage with cutting-edge RBQM strategies and techniques. As the event approaches, CluePoints encourages all interested parties to register and participate in shaping the future of clinical trials.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.